SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Seattle Genetics, Inc. Announces Initiation of a Phase Ib Trial of SGN-75 in Combination With Everolimus for Patients With Renal Cell Carcinoma